By Donna Kardos Yesalavich

U.S. stocks wobbled Monday, as declining crude-oil prices dragged down energy stocks and technology stocks lagged following reports that Google may close its Chinese-language site.

The Dow Jones Industrial Average (DJI) was down 7 points, or 0.1%, to 10617, in recent trading. Caterpillar Inc. (CAT) was the measure's worst performer, down 2.1%.

Energy components Exxon Mobil Corp. (XOM) and Chevron Corp. (CVX) were both weak as crude-oil futures fell below $80 per barrel. Exxon fell 0.8%, while Chevron slipped 0.6%.

Offsetting some of the declines, Wal-Mart Stores Inc. (WMT) shares gained 2.4% after Citigroup upgraded the retail giant to buy from hold, predicting more aggressive pricing.

The Nasdaq Composite (RIXF) dropped 0.3%, weighed down by a 2.6% drop in the shares of Google, Inc. The company appears increasingly likely to shutter its Chinese-language search engine, a step that would remove one of the last major foreign players from the world's most populous and fastest-growing Internet market.

American depository shares of Chinese Internet company Baidu (BIDU) jumped 7%, as it stands to become a monopoly if Google exits China.

The Standard & Poor's 500 (SPX) slipped 0.2%, with its energy and technology sectors leading the drop. Consumer staples and utilities posted modest gains.

In the first major acquisition in retail circles in years, apparel giant Phillips-Van Heusen Corp. (PVH) agreed to acquire privately-held clothing company Tommy Hilfiger for EUR 2.2 billion ($3 billion), largely in cash. Phillips-Van Heusen shares rose 10%.

Jeffrey Phillips, chief investment officer at Rehmann, said while the recent pick-up in mergers and acquisitions is a good long-term sign of improving business stability, the takeover poses more immediate concerns on the employment front.

"If you see a consolidation there, you'll see some efficiencies, which means more unemployment," he said. The market is seeing "more of that activity, which is good for profitability, but not a good indicator of economic recovery, at least in the short term."

Moody's Investors Service said the risks are growing to the four largest triple-A-rated countries: Germany, France, the U.K. and the U.S.

In addition, Chinese Premier Wen Jiabao warned of a double-dip recession given financial system risks and continued high unemployment in some countries.

Many investors have already priced in to the market those concerns, Phillips said.

Still, investors on Monday were drawn to the safety of the dollar. The U.S. Dollar Index (DXY), which tracks the greenback against a basket of six currencies, rose 0.4%. Meanwhile, Treasurys edged lower, with the 10-year note down 7/32 to yield 3.727%, while gold futures edged up.

Economic wrap

Monday's U.S. economic reports delivered mixed messages. The Federal Reserve Bank of New York's Empire Manufacturing Survey showed a decrease in its business conditions index to 22.86 this month from 24.91 in February. But the report said conditions "continued to improve at a steady pace in March," including a rise in new orders and improvement in labor markets.

U.S. industries reduced manufacturing output in February because of severe weather, while overall production totals inched ahead slightly. Industrial production last month increased by 0.1%, the Federal Reserve said, in line with economists' expectations.

Still, manufacturing production in February decreased 0.2% from the previous month's 0.9% increase, the report said. Car and parts output showed a steep dip of 4.4%. Excluding autos, production in all other industry remained stagnant.

Among stocks in focus, Amylin Pharmaceuticals (AMLN) shares jumped 8.7% after the Food and Drug Administration said it didn't want more clinical data on a diabetes drug it is developing with Eli Lilly (LLY) and Alkermes (ALKS). Lilly shares were up 0.1% while Alkermes climbed 10%.

Boston Scientific (BSX) dropped 13% on a report it's stopped selling a form of defibrillator.

 
 
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Amylin Pharmaceuticals, Inc. (MM) Charts.
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Amylin Pharmaceuticals, Inc. (MM) Charts.